Literature DB >> 11245848

Mechanisms involved in the blunted nitric oxide-cGMP pathway in hypertensive TGR(mREN2)27 rats.

K Jacke1, K Witte, B Lemmer.   

Abstract

In hypertensive TGR(mREN2)27 rats (TGR), the subsensitivity of vascular guanylyl cyclase to nitric oxide could depend on oxidized heme, reduced heme content, or decreased expression of the enzyme. In this study, enzyme activity was stimulated by protoporphyrin-IX, which acts independently of heme, and expression was assessed by Western blot analysis. In TGR aorta, maximum stimulation of soluble guanylyl cyclase by protoporphyrin-IX was 40% lower than in Sprague-Dawley controls, and expression of the beta1-subunit of the enzyme was reduced by 50% (P<0.05, t-test). In conclusion, decreased expression of soluble guanylyl cyclase leads to a blunted response of the nitric oxide-cGMP (guanosine 3',5'-cyclic monophosphate) pathway in TGR aorta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245848     DOI: 10.1016/s0014-2999(01)00806-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.

Authors:  Pierre-Antoine Crassous; Samba Couloubaly; Can Huang; Zongmin Zhou; Padmamalini Baskaran; David D Kim; Andreas Papapetropoulos; Xavier Fioramonti; Walter N Durán; Annie Beuve
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

Review 2.  Genetic modification of hypertension by sGCα1.

Authors:  Patrick Y Sips; Emmanuel S Buys
Journal:  Trends Cardiovasc Med       Date:  2013-06-05       Impact factor: 6.677

3.  Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.

Authors:  Emmanuel S Buys; Michael J Raher; Andrew Kirby; Mohd Shahid; Shahid Mohd; David M Baron; Sarah R Hayton; Laurel T Tainsh; Patrick Y Sips; Kristen M Rauwerdink; Qingshang Yan; Robert E T Tainsh; Hannah R Shakartzi; Christine Stevens; Kelly Decaluwé; Maria da Gloria Rodrigues-Machado; Rajeev Malhotra; Johan Van de Voorde; Tong Wang; Peter Brouckaert; Mark J Daly; Kenneth D Bloch
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.